The "PK DDI" corpus is a new corpus of sections from FDA-approved drug package inserts (PIs) that have been manually annotated for pharmacokinetic drug-drug interactions by a pharmacist and a drug information expert. The two annotators reached consensus on 592 PK DDIs, 3,351 active ingredient mentions, 234 drug product mentions, and 201 metabolite mentions present in over 200 PI sections extracted from 64 drug PIs. The corpus is provided to the non-profit research community under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Richard D. Boyce
University of Pittsburgh
Boyce R, Gardner G, Harkema H. Using Natural Language Processing to Extract Drug-Drug Interaction Information from Package Inserts. Proceedings of the 2012 Workshop on BioNLP. Montreal, Quebec, Canada. June 8, 2012. http://www.aclweb.org/anthology/W/W12/W12-2426.pdf.